Pinnacle Associates’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $162K | Hold |
|
|||||
|
2025
Q2 | $60.2K | Sell |
|
|||||
|
2025
Q1 | $88.5K | Sell |
|
|||||
|
2024
Q4 | $137K | Sell |
|
|||||
|
2024
Q3 | $847K | Buy |
|
|||||
|
2024
Q2 | $624K | Sell |
|
|||||
|
2024
Q1 | $764K | Buy |
|
|||||
|
2023
Q4 | $847K | Sell |
|
|||||
|
2023
Q3 | $283K | Buy |
|
|||||
|
2023
Q2 | $347K | Buy |
|
|||||
|
2023
Q1 | $392K | Buy |
|
|||||
|
2022
Q4 | $1.49M | Sell |
|
|||||
|
2022
Q3 | $1.63M | Sell |
|
|||||
|
2022
Q2 | $1.64M | Sell |
|
|||||
|
2022
Q1 | $1.21M | Buy |
|
|||||
|
2021
Q4 | $1.28M | Sell |
|
|||||
|
2021
Q3 | $3.15M | Sell |
|
|||||
|
2021
Q2 | $5.74M | Buy |
|
|||||
|
2021
Q1 | $7.49M | Sell |
|
|||||
|
2020
Q4 | $7.66M | Buy |
|
|||||
|
2020
Q3 | $9.53M | Sell |
|
|||||
|
2020
Q2 | $13.7M | Sell |
|
|||||
|
2020
Q1 | $8.5M | Sell |
|
|||||
|
2019
Q4 | $18.8M | Buy |
|
|||||
|
2019
Q3 | $8.92M | Buy |
|
|||||
|
2019
Q2 | $8.72M | Buy |
|
|||||
|
2019
Q1 | $7.24M | Sell |
|
|||||
|
2018
Q4 | $8.45M | Sell |
|
|||||
|
2018
Q3 | $8.52M | Sell |
|
|||||
|
2018
Q2 | $8.78M | Sell |
|
|||||
|
2018
Q1 | $45.7M | Sell |
|
|||||
|
2017
Q4 | $43.4M | Sell |
|
|||||
|
2017
Q3 | $36M | Sell |
|
|||||
|
2017
Q2 | $34M | Sell |
|
|||||
|
2017
Q1 | $27.2M | Buy |
|
|||||
|
2016
Q4 | $1.46M | Buy |
|